Lexicon Pharmaceuticals (STU:LX31) Accounts Payable & Accrued Expense : €14.37 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Lexicon Pharmaceuticals Accounts Payable & Accrued Expense?

Lexicon Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2023 (€19.87 Mil) to Dec. 2023 (€18.95 Mil) and declined from Dec. 2023 (€18.95 Mil) to Mar. 2024 (€14.37 Mil).

Lexicon Pharmaceuticals's annual accounts payable & accrued expense declined from Dec. 2021 (€13.56 Mil) to Dec. 2022 (€13.26 Mil) but then increased from Dec. 2022 (€13.26 Mil) to Dec. 2023 (€18.95 Mil).

Lexicon Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lexicon Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexicon Pharmaceuticals Accounts Payable & Accrued Expense Chart

Lexicon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

39.72

23.35

13.56

13.26

18.95

Lexicon Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															13.76	15.92	19.87	18.95	14.37

Lexicon Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lexicon Pharmaceuticals (STU:LX31) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexicon Pharmaceuticals Inc (STU:LX31) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

LXRX:USA

Address

2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381

Website

https://www.lexpharma.com

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Lexicon Pharmaceuticals (STU:LX31) Headlines

No Headlines